Torthaí cuardaigh - Thomas Ischinger

  • 1 - 15 toradh as 15 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Acute occlusion after percutaneous transluminal coronary angioplasty--a new approach.

    Acute occlusion after percutaneous transluminal coronary angioplasty--a new approach. de réir Jay Hollman, Andreas R. Gruentzig, John S. Douglas, Spencer B. King, Thomas Ischinger, Bernhard Meier

    Foilsithe / Cruthaithe 1983
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    A Randomized Study of Coronary Angioplasty Compared with Bypass Surgery in Patients with Symptomatic Multivessel Coronary Disease

    A Randomized Study of Coronary Angioplasty Compared with Bypass Surgery in Patients with Symptomatic Multivessel Coronary Disease de réir Christian W. Hamm, Jacobus Reimers, Thomas Ischinger, Hans‐Jürgen Rupprecht, Jürgen Berger, W. Bleifeld

    Foilsithe / Cruthaithe 1994
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Repeat coronary angioplasty

    Repeat coronary angioplasty de réir Bernhard Meier, Spencer B. King, Andreas R. Gruentzig, John S. Douglas, Jay Hollman, Thomas Ischinger, Kathy Galan, R Tankersley

    Foilsithe / Cruthaithe 1984
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Should coronary arteries with less than 60% diameter stenosis be treated by angioplasty?

    Should coronary arteries with less than 60% diameter stenosis be treated by angioplasty? de réir Thomas Ischinger, Andreas R. Gruentzig, Jay Hollman, Spencer B. King, John S. Douglas, Bernhard Meier, James M. Bradford, R Tankersley

    Foilsithe / Cruthaithe 1983
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Immediate and short-term benefit of multilesion coronary angioplasty: Influence of degree of revascularization

    Immediate and short-term benefit of multilesion coronary angioplasty: Influence of degree of revascularization de réir Michel Vandormael, Bernard R. Chaitmanz, Thomas Ischinger, Ümit T. Aker, Michael Harper, Jorge Gaspar Hernández, Ubeydullah Deligönül, Harold L. Kennedy

    Foilsithe / Cruthaithe 1985
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Embolic protection devices for carotid artery stenting: better results than stenting without protection?

    Embolic protection devices for carotid artery stenting: better results than stenting without protection? de réir R. Zahn, B. Màrk, N. Niedermaier, Uwe Zeymer, P Limbourg, Thomas Ischinger, K Haerten, Karl Eugen Hauptmann, Enz-Rüdiger von Leitner, Wolfgang Kasper

    Foilsithe / Cruthaithe 2004
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Carotid artery stenting in octogenarians: results from the ALKK Carotid Artery Stent (CAS) Registry

    Carotid artery stenting in octogenarians: results from the ALKK Carotid Artery Stent (CAS) Registry de réir Ralf Zahn, Thomas Ischinger, Matthias Hochadel, Uwe Zeymer, Wolfgang Schmalz, N. Treese, Karl Eugen Hauptmann, Hubert Seggewiß, Ilse Janicke, Hartwig Haase, Harald Mudra, Jochen Senges

    Foilsithe / Cruthaithe 2006
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Percutaneous transluminal coronary angioplasty in patients with prior coronary bypass surgery

    Percutaneous transluminal coronary angioplasty in patients with prior coronary bypass surgery de réir John S. Douglas, Andreas R. Gruentzig, Spencer B. King, Jay Hollman, Thomas Ischinger, Bernhard Meier, Joseph M. Craver, Ellis L. Jones, John L. Waller, David Bone, Robert A. Guyton

    Foilsithe / Cruthaithe 1983
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer

    The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer de réir Scot Garg, Giovanna Sarno, Patrick Serruys, Ton de Vries, Paweł Buszman, Axel Linke, Thomas Ischinger, Volker Klauß, Franz R. Eberli, Roberto Corti, William Wijns, Marie‐Claude Morice, Carlo Di Mario, Robert‐Jan van Geuns, Pedro Eerdmans, Gerrit-Anne van Es, Bernhard Meier, Peter Jüni, Stephan Windecker

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Value of the SYNTAX Score for Risk Assessment in the All-Comers Population of the Randomized Multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) Trial

    Value of the SYNTAX Score for Risk Assessment in the All-Comers Population of the Randomized Multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) Trial de réir Joanna J. Wykrzykowska, Scot Garg, Chrysafios Girasis, Ton de Vries, Marie-Angèle Morel, Gerrit-Anne van Es, Paweł Buszman, Axel Linke, Thomas Ischinger, Volker Klauß, Roberto Corti, Franz R. Eberli, William Wijns, Marie‐Claude Morice, Carlo Di Mario, Robert‐Jan van Geuns, Peter Jüni, Stephan Windecker, Patrick W. Serruys

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Improved Safety and Reduction in Stent Thrombosis Associated With Biodegradable Polymer-Based Biolimus-Eluting Stents Versus Durable Polymer-Based Sirolimus-Eluting Stents in Patients With Coronary Artery Disease

    Improved Safety and Reduction in Stent Thrombosis Associated With Biodegradable Polymer-Based Biolimus-Eluting Stents Versus Durable Polymer-Based Sirolimus-Eluting Stents in Patie... de réir Patrick W. Serruys, Vasim Farooq, Bindu Kalesan, Ton de Vries, Paweł Buszman, Axel Linke, Thomas Ischinger, Volker Klauß, Franz R. Eberli, William Wijns, Marie Claude Morice, Carlo Di Mario, Roberto Corti, Diethmar Antoni, Hae Young Sohn, Pedro Eerdmans, Tessa Rademaker‐Havinga, Gerrit‐Anne van Es, Bernhard Meier, Peter Jüni, Stephan Windecker

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Value of Age, Creatinine, and Ejection Fraction (ACEF Score) in Assessing Risk in Patients Undergoing Percutaneous Coronary Interventions in the ‘All-Comers' LEADERS Trial

    Value of Age, Creatinine, and Ejection Fraction (ACEF Score) in Assessing Risk in Patients Undergoing Percutaneous Coronary Interventions in the ‘All-Comers' LEADERS Trial de réir Joanna J. Wykrzykowska, Scot Garg, Yoshinobu Onuma, Ton de Vries, Dick Goedhart, Marie-Angèle Morel, Gerrit‐Anne van Es, Paweł Buszman, Axel Linke, Thomas Ischinger, Volker Klauß, Roberto Corti, Franz R. Eberli, William Wijns, Marie‐Claude Morice, Carlo Di Mario, Robert‐Jan van Geuns, Peter Jüni, Stephan Windecker, Patrick W. Serruys

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    The Impact of Patient and Lesion Complexity on Clinical and Angiographic Outcomes After Revascularization With Zotarolimus- and Everolimus-Eluting Stents

    The Impact of Patient and Lesion Complexity on Clinical and Angiographic Outcomes After Revascularization With Zotarolimus- and Everolimus-Eluting Stents de réir Giulio Stefanini, Patrick W. Serruys, Sigmund Silber, Ahmed A. Khattab, Robert‐Jan van Geuns, Gert Richardt, Paweł Buszman, Henning Kelbæk, Adrianus J. van Boven, Sjoerd H. Hofma, Axel Linke, Volker Klauß, William Wijns, Carlos Macaya, Philippe Garot, Carlo Di Mario, Ganesh Manoharan, Ran Kornowski, Thomas Ischinger, Antonio L. Bartorelli, Pierre Gobbens, Stephan Windecker

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    The Prognostic Utility of the SYNTAX Score on 1-Year Outcomes After Revascularization With Zotarolimus- and Everolimus-Eluting Stents

    The Prognostic Utility of the SYNTAX Score on 1-Year Outcomes After Revascularization With Zotarolimus- and Everolimus-Eluting Stents de réir Scot Garg, Patrick W. Serruys, Sigmund Silber, Joanna J. Wykrzykowska, Robert‐Jan van Geuns, Gert Richardt, Paweł Buszman, Henning Kelbæk, Adrianus J. van Boven, Sjoerd H. Hofma, Axel Linke, Volker Klauß, William Wijns, Carlos Macaya, Philippe Garot, Carlo Di Mario, Ganesh Manoharan, Ran Kornowski, Thomas Ischinger, Antonio L. Bartorelli, Eric van Remortel, Jacintha E. Ronden, Stephan Windecker

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents

    Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents de réir Patrick W. Serruys, Sigmund Silber, Scot Garg, Robert‐Jan van Geuns, Gert Richardt, Paweł Buszman, Henning Kelbæk, Adrianus J. van Boven, Sjoerd H. Hofma, Axel Linke, Volker Klauß, William Wijns, Carlos Macaya, Philippe Garot, Carlo Di Mario, Ganesh Manoharan, Ran Kornowski, Thomas Ischinger, Antonio L. Bartorelli, Jacintha E. Ronden, Marco Bressers, Pierre Gobbens, Manuela Negoita, Frank N. van Leeuwen, Stephan Windecker

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: